| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 225,798 | 257,349 | 437,943 | 407,775 | | Cost of Revenue | 129,551 | 152,629 | 300,355 | 259,601 | | | Gross Profit | 96,247 | 104,720 | 137,588 | 148,174 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,514 | 49,519 | 53,464 | 57,999 | | Non Recurring | 25,971 |
-
| 17,330 | 91,782 | | Others | 29,823 | 29,387 | 33,325 | 36,264 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,910 | 25,814 | 33,469 | (37,871) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22,345 | 34,241 | 17,407 | 2,601 | | Earnings Before Interest And Taxes | 13,284 | 60,055 | 50,876 | (35,270) | | Interest Expense | 20,691 | 23,338 | 18,901 | 113,403 | | Income Before Tax | (7,407) | 36,717 | 31,975 | (148,673) | | Income Tax Expense | (3,435) | 13,712 | 6,023 | (51,384) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,853) | 24,581 | 25,625 | (96,579) | | | Non-recurring Events | | Discontinued Operations | 1,673 |
-
| 766 | (2,239) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,180) | 24,581 | 26,391 | (98,818) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,180) | $24,581 | $26,391 | ($98,818) |
|
0.01% Nasdaq 0.00%
Income Statement
